
Building Better CDMO Relationships: ten23 health’s Blueprint for Successful Pharmaceutical Partnerships
“My ambition for being a CDMO is that there will always be technical challenges, but I want to be transparent about the challenge and provide options to a customer.”
Hanns-Christian Mahler, CEO of ten23 health, brings 15 years of sponsor-side experience to his current role leading a sterile product CDMO focused on drug product development, manufacturing and testing. His unique perspective from both sides of the outsourcing relationship provides valuable insights into building successful partnerships.
In the latest PharmaSource podcast episode recorded at CDMO Live 2025, Hanns explains why transparency, realistic planning and early development integration are essential strategies for avoiding costly manufacturing failures and building sustainable relationships.
D'autres épisodes de "PharmaSource Podcast"
Ne ratez aucun épisode de “PharmaSource Podcast” et abonnez-vous gratuitement à ce podcast dans l'application GetPodcast.